Cannabis Use, Cognition, and the Endocannabinoid System in HIV

NCT04883255 · clinicaltrials.gov ↗

EARLY_PHASE1

Phase

RECRUITING

Status

138

Enrollment

OTHER

Sponsor class

Conditions

HIV-1-infection

Interventions

DRUG: 10 mg Δ9-tetrahydrocannabinol (THC)
DRUG: 600 mg cannabidiol (CBD)
DRUG: Placebo

Sponsor

University of California, San Diego

Collaborators

[object Object]